Exicure, Inc. Files 8-K: Other Events & Financials
Ticker: XCUR · Form: 8-K · Filed: Aug 19, 2024 · CIK: 1698530
| Field | Detail |
|---|---|
| Company | Exicure, Inc. (XCUR) |
| Form Type | 8-K |
| Filed Date | Aug 19, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-filing, pharmaceuticals
TL;DR
EXICURE FILES 8-K - REGULAR BUSINESS UPDATE
AI Summary
Exicure, Inc. filed an 8-K on August 19, 2024, reporting on other events and financial statements. The company, formerly known as Max-1 Acquisition Corp, is incorporated in Delaware and operates in the pharmaceutical preparations sector.
Why It Matters
This filing provides an update on Exicure, Inc.'s corporate activities and financial reporting, which is crucial for investors to understand the company's current status and regulatory compliance.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for 'Other Events' and financial statements, not indicating any immediate or significant new risks.
Key Numbers
- 001-39011 — SEC File Number (Identifies the company's filing history with the SEC.)
- 81-5333008 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- EXICURE, INC. (company) — Registrant
- Max-1 Acquisition Corp (company) — Former company name
- August 19, 2024 (date) — Date of earliest event reported
- 2430 N. Halsted St. (location) — Principal executive offices address
- Chicago, IL 60614 (location) — Principal executive offices address
FAQ
What specific 'Other Events' are being reported by Exicure, Inc. in this 8-K filing?
The filing indicates 'Other Events' as an item information, but the specific details of these events are not provided in the excerpt.
When was Exicure, Inc. formerly known as Max-1 Acquisition Corp?
The date of the name change from Max-1 Acquisition Corp to Exicure, Inc. was February 21, 2017.
What is Exicure, Inc.'s primary industry classification?
Exicure, Inc. is classified under 'PHARMACEUTICAL PREPARATIONS' with the SIC code 2834.
Where are Exicure, Inc.'s principal executive offices located?
The principal executive offices of Exicure, Inc. are located at 2430 N. Halsted St., Chicago, IL 60614.
What is the fiscal year end for Exicure, Inc.?
Exicure, Inc.'s fiscal year ends on December 31st.
Filing Stats: 699 words · 3 min read · ~2 pages · Grade level 10.4 · Accepted 2024-08-19 11:24:54
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share XCUR The Nasdaq Stock Market
Filing Documents
- xcur-20240819.htm (8-K) — 27KB
- a8k81924exhibit991.htm (EX-99.1) — 8KB
- exicureimage1a10.gif (GRAPHIC) — 3KB
- 0001698530-24-000093.txt ( ) — 162KB
- xcur-20240819.xsd (EX-101.SCH) — 2KB
- xcur-20240819_lab.xml (EX-101.LAB) — 21KB
- xcur-20240819_pre.xml (EX-101.PRE) — 12KB
- xcur-20240819_htm.xml (XML) — 3KB
01 Other Events
Item 8.01 Other Events. Exicure, Inc. (Nasdaq: XCUR, the "Company") announced today that its Special Meeting of Stockholders (the "Special Meeting") initially scheduled for August 15, 2024 and adjourned and reconvened on August 19, 2024, has been adjourned again for the purpose of soliciting additional votes with respect to the proposal described in the Company's definitive proxy statement for the Special Meeting filed with the Securities and Exchange Commission (the "SEC") on July 30, 2024. The presence, in person, by remote communication or by proxy, of the holders of a majority of the outstanding shares of stock entitled to vote constitutes a quorum. There was less than the required majority represented at the reconvened Special Meeting, so a quorum did not exist. At the time the Special Meeting was adjourned on August 19, 2024, proxies had been submitted by stockholders representing approximately 49.7% of the outstanding shares of stock entitled to vote. The Special Meeting will be reconvened again on August 20, 2024 at 9:00 a.m. Central Time and will continue to be held virtually and exclusively online via live audio-only webcast at www.virtualshareholdermeeting.com/XCUR2024SM. The record date for determination of stockholders entitled to vote at the reconvened Special Meeting remains July 26, 2024. Proxies previously submitted in respect of the Special Meeting will be voted at the adjourned Special Meeting unless properly revoked, and stockholders who have previously submitted a proxy or otherwise voted need not take any action. Stockholders who have not yet voted are encouraged to vote as soon as possible via the Internet at www.proxyvote.com or by phone at 1-800-690-6903. You will be asked to provide the control number from your proxy card and follow the instructions. If you are a beneficial owner of shares registered in the name of your broker, bank or other agent, you should have received these proxy materials and a voting instructions from t
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 99.1 Press release dated August 19, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 19, 2024 EXICURE, INC. By: /s/ Paul Kang Paul Kang Chief Executive Officer